Raul C. Ribeiro, MD

Raul C. Ribeiro, MD, is a member of the Division of Leukemia/Lymphoma, Department of Oncology, at St. Jude Children’s Research Hospital in Memphis, TN. He is also a professor in the Department of Pediatrics at The University of Tennessee Health Science Center in Memphis.

Dr Ribeiro’s research interests include acute myeloid leukemia (AML), acute lymphoblastic leukemia, and adrenocortical carcinoma. He was the principal investigator of the St. Jude frontline AML97 study and a coinvestigator of the St. Jude frontline AML02, AML08, and AML16 studies. Recently, he has focused on clinical investigation to decrease the intensity of AML treatment in regions with limited resources, including South America, Central America, and China. He is also conducting a study of CPX-351 in children and adolescents with secondary AML/myelodysplastic syndromes.